CD8A and neoplasm: CD8+T cells have the ability to selectively recognize and kill cancer cells due to specific responses to tumor-expressed antigens, including tumor-specific (mutants and viruses) neoantigens and autoantigens (also known as tumor-associated or shared antigens) [34–41].